In terms of survival, patients with a focal (p = 0.040) and multifocal (p = 0.033) distribution of FoxP3+ cells exhibit significantly decreased overall survival and higher risk of tumor-related death, compared with those with absent FoxP3+ cells (Figure 5). The gene discussed is FOXP3; the disease is neoplasm.